ArticleJournal of the Korean Society of Radiology2026
Predictive Factors for Distant Metastasis in Follicular Thyroid Carcinoma: Analysis of Clinical, Genetic, and Radiomics Features.
Article in Journal of the Korean Society of Radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular Markers in Follicular Thyroid Carcinoma: Moving Toward Better Prediction of Distant Metastasis.Journal of the Korean Society of Radiology · 2026Article
- Autophagy in thyroid cancer: stage-dependent switch, mutation-specific regulation, and therapeutic targeting.Oncology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Distant metastasis in follicular thyroid carcinoma (FTC) significantly affects prognosis and treatment strategies. This study aimed to identify the most effective predictors of distant metastasis in patients with FTC. Materials and Methods: We conducted a retrospective analysis of 105 FTC cases (8 with distant metastasis and 97 without) from 1997 to 2018 at a single tertiary hospital. We analyzed the clinicopathological characteristics, genetic markers (RAS and telomerase reverse transcriptase [TERT] promoter mutations), and various US features. Radiomics features were extracted from the US images and assessed using five classifier models. Variables with Results: The metastasis group showed significant age differences (61.1 ± 12.2 vs. 43.8 ± 13.5 years, Conclusion: Advanced age patients with FTC and positive TERT and RAS mutations require vigilant management. Currently, radiomics texture analysis has limited value for metastasis prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.